Skip to main content
SpringerLink
Log in

Postoperative Radiotherapy for Prostate Cancer

  • Chapter
  • First Online:
Radiation Therapy for Genitourinary Malignancies

Part of the book series: Practical Guides in Radiation Oncology ((PGRO))

  • 647 Accesses

Abstract

Radical prostatectomy comprises initial treatment in 50% of men with prostate cancer, and many patients after surgery require additional treatment. In this chapter, we review the indications for radiation and adjuvant hormonal therapy in the postoperative setting. We discuss the incorporation of next-generation imaging as well as emerging biomarkers in informing these clinical decisions. Finally, we propose a practical guide for postoperative radiotherapy, as well as management of frequent on-treatment issues.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Young HH (2002) The early diagnosis and radical cure of carcinoma of the prostate: being a study of 40 cases and presentation of a radical operation which was carried out in four cases. 1905. J Urol 167(2 Pt 2):939–946; discussion 947

    Article  Google Scholar 

  2. Cooperberg MR, Broering JM, Carroll PR (2010) Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol 28:1117–1123

    Article  Google Scholar 

  3. Roehl KA, Han M, Ramos CG, Antenor JAV, Catalona WJ (2004) Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. J Urol 172:910–914

    Article  Google Scholar 

  4. Han M, Partin AW, Pound CR, Epstein JI, Walsh PC (2001) Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy: the 15-year Johns Hopkins experience. Urol Clin North Am 28:555–565

    Article  CAS  Google Scholar 

  5. Chun K-H, Graefen M, Zacharias M, Haese A, Steuber T, Schlomm T, Walz J, Karakiewicz PI, Huland H (2006) Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancer. World J Urol 24(3):273–280. https://doi.org/10.1007/s00345-006-0058-2

    Article  PubMed  Google Scholar 

  6. Cookson MS et al (2007) Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association prostate guidelines for localized prostate cancer update panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol 177:540–545

    Article  CAS  Google Scholar 

  7. Connolly JA, Shinohara K, Presti JC Jr, Carroll PR (1996) Local recurrence after radical prostatectomy characteristics in size, location, and relationship to prostate-specific antigen and surgical margins. Urology 47(2):225–231

    Article  CAS  Google Scholar 

  8. Pound CR et al (1999) Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281:1591–1597

    Article  CAS  Google Scholar 

  9. Thompson IM et al (2013) Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO guideline. J Urol 190:441. https://doi.org/10.1016/j.juro.2013.05.032

    Article  PubMed  Google Scholar 

  10. Swindle P et al (2005) Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 174:903–907

    Article  Google Scholar 

  11. Lowe BA, Lieberman SF (1997) Disease recurrence and progression in untreated pathologic stage T3 prostate cancer: selecting the patient for adjuvant therapy. J Urol 158:1452–1456

    Article  CAS  Google Scholar 

  12. Lee HM, Solan MJ, Lupinacci P, Gomella LG, Valicenti RK (2004) Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy. Urology. https://doi.org/10.1016/j.urology.2004.02.004

  13. Trock BJ et al (2008) Prostate cancer–specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy. JAMA 299:2760

    Article  CAS  Google Scholar 

  14. Stephenson AJ et al (2005) Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol 23:7005. https://doi.org/10.1200/JCO.2005.01.867

    Article  PubMed  PubMed Central  Google Scholar 

  15. Thompson IM et al (2009) Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term follow-up of a randomized clinical trial. J Urol 181:956–962

    Article  Google Scholar 

  16. Bolla M et al (2005) Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet 366:572. https://doi.org/10.1016/S0140-6736(05)67101-2

    Article  PubMed  Google Scholar 

  17. Wiegel T et al (2009) Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95. J Clin Oncol 27:2924–2930

    Article  Google Scholar 

  18. Moinpour CM et al (2008) Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy. J Clin Oncol 26(112–120):112

    Article  Google Scholar 

  19. Kneebone A et al. (2019) A phase III multi-centre randomised trial comparing adjuvant versus early salvage radiotherapy following a radical prostatectomy: results of the TROG 08.03 and ANZUP ‘RAVES’ trial. In: ASTRO annual meeting

    Google Scholar 

  20. Parker C et al (2019) Timing of radiotherapy (RT) after radical prostatectomy (RP): first results from RADICALS-RT randomised controlled trial. Ann Oncol 30:v883–v884

    Article  Google Scholar 

  21. Vale C et al (2019) Adjuvant or salvage radiotherapy for the treatment of localised prostate cancer? A prospectively planned aggregate data meta-analysis. Ann Oncol 30:v883

    Article  Google Scholar 

  22. Abdollah F et al (2013) Extended pelvic lymph node dissection in prostate cancer: a 20-year audit in a single center. Ann Oncol 24(6):1459–1466. https://doi.org/10.1093/annonc/mdt120

    Article  CAS  PubMed  Google Scholar 

  23. Abdollah F et al (2010) Decreasing rate and extent of lymph node staging in patients undergoing radical prostatectomy may undermine the rate of diagnosis of lymph node metastases in prostate cancer. Eur Urol. https://doi.org/10.1016/j.eururo.2010.09.029

  24. Briganti A et al (2011) Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-T4 pN+ prostate cancer: results of a matched analysis. Eur Urol 59:832–840

    Article  CAS  Google Scholar 

  25. Touijer KA et al (2018) Survival outcomes of men with lymph node-positive prostate cancer after radical prostatectomy: a comparative analysis of different postoperative management strategies. Eur Urol 73:890. https://doi.org/10.1016/j.eururo.2017.09.027

    Article  PubMed  Google Scholar 

  26. Abdollah F et al (2014) Impact of adjuvant radiotherapy on survival of patients with node-positive prostate cancer. J Clin Oncol 32:3939–3947

    Article  Google Scholar 

  27. Mohler J et al. (2020) NCCN clinical practice guidelines in oncology: Prostate Cancer Version 1.2020

    Google Scholar 

  28. Stephenson AJ et al (2007) Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol 20:2035–2041

    Article  Google Scholar 

  29. Tendulkar RD et al (2016) Contemporary update of a multi-institutional predictive nomogram for salvage radiotherapy after radical prostatectomy. J Clin Oncol 34:3648. https://doi.org/10.1200/JCO.2016.67.9647

    Article  PubMed  Google Scholar 

  30. Lamy P-J et al (2017) Prognostic biomarkers used for localised prostate cancer management: a systematic review. Eur Urol Focus 4:790. https://doi.org/10.1016/j.euf.2017.02.017

    Article  PubMed  Google Scholar 

  31. Den RB et al (2015) Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy. J Clin Oncol 33:944. https://doi.org/10.1200/JCO.2014.59.0026

    Article  PubMed  PubMed Central  Google Scholar 

  32. Dalela D et al (2017) Genomic classifier augments the role of pathological features in identifying optimal candidates for adjuvant radiation therapy in patients with prostate cancer: development and internal validation of a multivariable prognostic model. J Clin Oncol 35:1982. https://doi.org/10.1200/JCO.2016.69.9918

    Article  PubMed  PubMed Central  Google Scholar 

  33. Roy C et al (2013) Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy. Am J Roentgenol 200:W361. https://doi.org/10.2214/AJR.12.9106

    Article  Google Scholar 

  34. Liauw SL et al (2013) Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging. Int J Radiat Oncol Biol Phys 85:378. https://doi.org/10.1016/j.ijrobp.2012.05.015

    Article  PubMed  Google Scholar 

  35. Evans JD et al (2018) Prostate cancer–specific PET radiotracers: a review on the clinical utility in recurrent disease. Pract Radiat Oncol 8:28–39

    Article  Google Scholar 

  36. Ost P et al (2017) Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence: a prospective, randomized, multicenter phase II trial. J Clin Oncol 36:446. https://doi.org/10.1200/JCO.2017.75.4853

    Article  PubMed  Google Scholar 

  37. Phillips R et al (2019) Primary outcomes of a phase II randomized trial of Observation Versus Stereotactic Ablative RadiatIon for OLigometastatic Prostate CancEr (ORIOLE). Int J Radiat Oncol Biol Phys 105

    Google Scholar 

  38. Briganti A et al (2012) Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis. Eur Urol 62:472. https://doi.org/10.1016/j.eururo.2012.04.056

    Article  PubMed  Google Scholar 

  39. Hwang WL et al (2018) Comparison between adjuvant and early-salvage postprostatectomy radiotherapy for prostate cancer with adverse pathological features. JAMA Oncol 4:e175230. https://doi.org/10.1001/jamaoncol.2017.5230

    Article  PubMed  PubMed Central  Google Scholar 

  40. Lupattelli M et al (2015) Adjuvant and salvage radiation therapy after prostatectomy: investigating beliefs and practices of radiation oncologists. Br J Radiol 88:20150587

    Article  Google Scholar 

  41. King CR (2012) The timing of salvage radiotherapy after radical prostatectomy: a systematic review. Int J Radiat Oncol Biol Phys 84:104. https://doi.org/10.1016/j.ijrobp.2011.10.069

    Article  PubMed  Google Scholar 

  42. Ghadjar P et al (2015) Acute toxicity and quality of life after dose-intensified salvage radiation therapy for biochemically recurrent prostate cancer after prostatectomy: first results of the randomized trial SAKK 09/10. J Clin Oncol 33:4158. https://doi.org/10.1200/JCO.2015.63.3529

    Article  CAS  PubMed  Google Scholar 

  43. Ghadjar P et al (2018) Impact of dose intensified salvage radiation therapy on urinary continence recovery after radical prostatectomy: results of the randomized trial SAKK 09/10. Radiother Oncol 126:257–262

    Article  Google Scholar 

  44. Picardi C, Perret I, Miralbell R, Zilli T (2018) Hypofractionated radiotherapy for prostate cancer in the postoperative setting: what is the evidence so far? Cancer Treat Rev 62:91. https://doi.org/10.1016/j.ctrv.2017.11.004

    Article  PubMed  Google Scholar 

  45. Siepe G, Buwenge M, Nguyen NP, Macchia G, Deodato F, Cilla S, Mattiucci GC, Capocaccia I, Cammelli S, Guido A et al (2018) Postoperative hypofractionated radiation therapy in prostate carcinoma: a systematic review. Anticancer Res 38:1221–1230

    PubMed  Google Scholar 

  46. Shipley WU et al (2017) Radiation with or without antiandrogen therapy in recurrent prostate cancer. N Engl J Med 376:417. https://doi.org/10.1056/NEJMoa1607529

    Article  PubMed  PubMed Central  Google Scholar 

  47. Groupe P et al (2019) Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial. Lancet Oncol 20:1740–1789

    Article  Google Scholar 

  48. Pollack A et al (2018) Short term androgen deprivation therapy without or with pelvic lymph node treatment added to prostate bed only salvage radiotherapy: the NRG Oncology/RTOG 0534 SPPORT trial LBA6 plasma circulating tumor HPV DNA for the surveillance of cancer recurrence in HPV-associated oropharyngeal. Cancer 102

    Google Scholar 

  49. Messing E et al (2006) Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy. Lancet Oncol 7:472–479

    Article  CAS  Google Scholar 

  50. Nguyen PL et al (2015) Adverse effects of androgen deprivation therapy and strategies to mitigate them. Eur Urol 67:825–836

    Article  CAS  Google Scholar 

  51. Dinh KT et al (2016) Association of androgen deprivation therapy with depression in localized prostate cancer. J Clin Oncol 34:1905. https://doi.org/10.1200/JCO.2015.64.1969

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Dinh KT et al (2017) Association between androgen deprivation therapy and anxiety among 78,000 patients with localized prostate cancer. Int J Urol 24:743–748

    Article  CAS  Google Scholar 

  53. Smith MR et al (2009) Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N Engl J Med 361:745–755

    Article  CAS  Google Scholar 

  54. Segal RJ et al (2003) Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 21:1653. https://doi.org/10.1200/JCO.2003.09.534

    Article  PubMed  Google Scholar 

  55. Crook JM et al (2012) Intermittent androgen suppression for rising PSA level after radiotherapy. N Engl J Med 367:895–903

    Article  CAS  Google Scholar 

  56. Irani J, Salomon L, Oba R, Bouchard P, Mottet N (2010) Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial. Lancet Oncol 147. https://doi.org/10.1016/S1470

  57. Wo JY, Zietman AL (2008) Why does androgen deprivation enhance the results of radiation therapy? Urol Oncol 26(5):522–529. https://doi.org/10.1016/j.urolonc.2008.03.008

    Article  CAS  PubMed  Google Scholar 

  58. Miralbell R et al (2007) Endorectal MRI assessment of local relapse after surgery for prostate cancer: a model to define treatment field guidelines for adjuvant radiotherapy in patients at high risk for local failure. Int J Radiat Oncol Biol Phys. https://doi.org/10.1016/j.ijrobp.2006.08.079

  59. Michalski JM et al (2010) Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer. Radiat Oncol Biol 76:361–368

    Article  Google Scholar 

  60. Marks LB et al (2010) Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 76:S10. https://doi.org/10.1016/j.ijrobp.2009.07.1754

    Article  PubMed  PubMed Central  Google Scholar 

  61. Pollack A et al (2015) A phase III trial of short term androgen deprivation with pelvic lymph node or prostate bed only radiotherapy (SPPORT) in prostate cancer patients with a rising PSA after radical prostatectomy. Int. Journal Radiat Oncol Biol Phys. 102(5);1605

    Google Scholar 

  62. Halperin EC, Brady LW, Perez CA, Wazer DE (2013) Perez and Brady’s principles and practice of radiation oncology. Lippincott Williams & Wilkins, Philadelphia

    Google Scholar 

  63. Jeong IG et al (2014) Impact of tamsulosin on urinary retention following early catheter removal after robot-assisted laparoscopic radical prostatectomy: a prospective randomized controlled trial. Int J Urol 21:164. https://doi.org/10.1111/iju.12225

    Article  CAS  PubMed  Google Scholar 

  64. Phillips TL, Hoppe R, Roach M, Leibel SA (2010) Leibel and Phillips textbook of radiation oncology. Elsevier/Saunders, Philadelphia

    Google Scholar 

  65. Tabaja L, Sidani SM (2018) Management of radiation proctitis. Dig Dis Sci 63:2180–2188

    Article  CAS  Google Scholar 

  66. Yoshimizu S et al (2017) Efficacy of hyperbaric oxygen therapy in patients with radiation-induced rectal ulcers: report of five cases. Dig Endosc 29:718–722

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, University of Washington Medical Center, Seattle, WA, USA

    Tru-Khang T. Dinh

  2. Sutter Health Radiation Oncology, Sacramento, CA, USA

    Meghan W. Macomber

  3. Department of Radiation Medicine, Oregon Health and Science University, Portland, OR, USA

    Timur Mitin

Authors
  1. Tru-Khang T. Dinh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Meghan W. Macomber
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Timur Mitin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tru-Khang T. Dinh .

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, Loyola University Chicago, Maywood, IL, USA

    Abhishek A. Solanki

  2. Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, KS, USA

    Ronald C. Chen

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Dinh, TK.T., Macomber, M.W., Mitin, T. (2021). Postoperative Radiotherapy for Prostate Cancer. In: Solanki, A.A., Chen, R.C. (eds) Radiation Therapy for Genitourinary Malignancies . Practical Guides in Radiation Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-65137-4_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-65137-4_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-65136-7

  • Online ISBN: 978-3-030-65137-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation